For Release: August 17, 2007 at 7:30 a.m. ET
CONTACT: Steve Tuttle
Vice President of Communications
TASER International, Inc.
Media ONLY Hotline: (480) 444-4000

TASER International Core Business Revenue Growing for Third Quarter
Receives Two Orders from Existing Customers to Increase Patrol Level Deployments

SCOTTSDALE, Ariz., August 17, 2007 – TASER International, Inc. (NASDAQ: TASR), a
market leader in advanced electronic control devices, today announced two orders from law
enforcement agencies. The first order originated from San Diego County Sheriff’s Department
in San Diego, California for 205 TASER® X26 Electronic Control Devices (ECDs) and related
accessories. This order increases their TASER X26 inventory to 1039 TASER ECDs for its
2100 sworn officers. The second order originated from Brevard County Sheriff’s Office in
Titusville, Florida for 200 TASER X26 ECDs and related accessories. Brevard County Sheriff’s
Office more than doubled its existing arsenal of TASER ECDs with this order.
“We believe the TASER system provides the best readily available force option on the market,”
said Sgt. John Pokorny of the San Diego County Sheriff’s Department. “We've long been a
leader when it comes to less-lethal-force options. Our ultimate goal is to reduce the use of lethal
force by providing reasonable alternative-force options,” continued Sgt. Pokorny.
“Our orders are growing from repeat customers contributing to our strengthening base-line
business,” commented Tom Smith, Chairman and Founder of TASER International. “These
follow-on orders include TASER ECDs, TASER Cartridges, and related accessories. Many of
our 11,500 client agencies are increasing the number of TASER ECDS for their patrol level
officers to protect life. This growth is helping to shape what looks like a strong third quarter.”
The two orders are expected to ship in the third quarter of 2007.
About TASER International, Inc.
TASER International provides advanced electronic control devices for use in the law
enforcement, military, private security and personal defense markets. TASER devices use
proprietary technology to incapacitate dangerous, combative or high-risk subjects who pose a
risk to law enforcement officers, innocent citizens or themselves in a manner that is generally
recognized as a safer alternative to other uses of force. TASER technology saves lives every day,
and the use of TASER devices dramatically reduces injury rates for police officers and suspects.
For more information on TASER life-saving technology, please call TASER International at
(800) 978-2737 or visit our website at www.TASER.com.
Note to Investors
This press release contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities

Exchange Act of 1934, as amended (the “Exchange Act”), including statements, without
limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We
intend that such forward-looking statements be subject to the safe-harbor provided by the Private
Securities Litigation Reform Act of 1995. The forward-looking information is based upon
current information and expectations regarding TASER International. These estimates and
statements speak only as of the date on which they are made, are not guarantees of future
performance, and involve certain risks, uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results could materially differ from what is expressed, implied,
or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained in this press
release. These statements are qualified by important factors that could cause our actual results to
differ materially from those reflected by the forward-looking statements. Such factors include
but are not limited to: (1) market acceptance of our products; (2) our ability to establish and
expand direct and indirect distribution channels; (3) our ability to attract and retain the
endorsement of key opinion-leaders in the law enforcement community; (4) the level of product
technology and price competition for our products; (5) the degree and rate of growth of the
markets in which we compete and the accompanying demand for our products; (6) risks
associated with rapid technological change and new product introductions; (7) competition; (8)
litigation including lawsuits resulting from alleged product related injuries and death; (9) media
publicity concerning allegations of deaths and injuries occurring after use of the TASER device
and the negative effect this publicity could have on our sales; (10) TASER device tests and
reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential
fluctuations in our quarterly operating results; (14) financial and budgetary constraints of
prospects and customers; (15) order delays; (16) dependence upon sole and limited source
suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component
pricing; (19) government regulations and inquiries; (20) dependence upon key employees and
our ability to retain employees; (21) execution and implementation risks of new technology; (22)
ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field
test results; and (25) other factors detailed in our filings with the Securities and Exchange
Commission, including, without limitation, those factors detailed in the Company’s Annual
Report on Form 10-K and its Form 10-Qs.
The statements made herein are independent statements of TASER International. The inclusion
of any third parties does not represent an endorsement of any TASER International products or
services by any such third parties.
###